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Abstract
The HIV Rev protein is known to facilitate export of incompletely spliced and
unspliced viral transcripts to the cytoplasm, a necessary step in virus life cycle. The
Rev-mediated nucleo-cytoplasmic transport of nascent viral transcripts,
dependents on interaction of Rev with the RRE RNA structural element present in
the target RNAs. The C-terminal variant of dsRNA-binding nuclear protein 90
(NF90ctv) has been shown to markedly attenuate viral replication in stably
transduced HIV-1 target cell line. Here we examined a mechanism of interference
of viral life cycle involving Rev-NF90ctv interaction. Since Rev:RRE complex
formations depends on protein:RNA and protein:protein interaction, we
investigated whether the expression of NF90ctv might interfere with Rev-mediated
export of RRE-containing transcripts. When HeLa cells expressed both NF90ctv
and Rev protein, we observed that NF90ctv inhibited the Rev-mediated RNA
transport. In particular, three regions of NF90ctv protein are involved in blocking
Rev function. Moreover, interaction of NF90ctv with the RRE RNA resulted in the
expression of reporter protein coding sequences linked to the RRE structure.
Moreover, Rev affects the subcellular localization of NF90ctv, and this process is
leptomycin B sensitive. The dsRNA binding protein, NF90ctv competes with HIV
Rev function at two levels, by competitive protein:protein interaction involving Rev
binding to specific domains of NF90ctv, as well as by its binding to the RRE-RNA
structure. Our results are consistent with a model of Rev function that envisions
Rev-multimerization, a process interrupted by NF90ctv.
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Background
Upon entering an uninfected host cell, the single-stranded RNA genome of Human
immunodeficiency virus type 1 (HIV-1) is copied into DNA by the viral reverse
transcriptase. Following integration of DNA into the host genome, transcriptional
activation of the proviral DNA generates progeny virions. The post-integration
events of transcription, RNA splicing, transport and translation of viral mRNAs are
regulated by coordinate interaction with host proteins. Strict dependence of viral
gene expression on host factors particularly those with protein:RNA and
protein:protein binding properties, are useful targets to explore novel antiviral
therapy.
Regulation of HIV-1 gene expression is controlled mainly by the two virus encoded
proteins, Tat responsible for elongation of processive transcription, and Rev which
regulates transport of unspliced and incompletely spliced viral transcripts from the
nucleus to the cytoplasm. These two regulatory proteins function by binding to
structured RNA domains, the trans-activation responsive RNA (TAR) and the Rev
response element (RRE) respectively, present in the viral transcripts.
The functional domains of Rev include an N-terminal nuclear localization signal
(NLS) rich in Arg-residues, and a C-terminal nuclear export signal (NES) rich in
Leu-residues. The NES of Rev interacts with host proteins that are critical for RNA
export, and the NLS binds to the RRE-RNA structure, and is also involved in Rev-
homodimerization [1-3]. Rev binds to importin-β  (Imp-β) in the cytoplasm that
allows its import back into the nucleus. Once in the nucleus, Rev interacts with the
RRE RNA present in the incompletely spliced and unspliced viral transcripts. The
newly formed Rev:RRE complex recruits proteins such as Crm1 [2] or eIF5A [1]
that are essential cofactors in regulating nuclear export [4,5]. The Rev:RRE:Crm1
complex is translocated through the nuclear pore complex to the cytoplasm where
it dissociates and the transcripts are recognized by the translation machinery for
synthesis of viral structural proteins [1]. Interaction of Rev with Crm1 occurs via the
NES present in both proteins [6] a process inhibited by the leptomycin B (LMB).
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The NES domains play a critical role in the intracellular localization of viral and
cellular proteins [7-9].
In murine fibroblast A9 cells, export of HIV-1 transcripts mediated by Rev is
restricted due to as yet unidentified host cell factor(s) that block Rev-mediated
transport. However the Rex protein, an analogue of Rev encoded by the Human T
cell leukemia virus type 1 (HTLV-1) is able to mediate RNA transport in murine
cells. Marques et al. [10] reported that a chimeric protein containing the N-terminal
region of Rev (amino acids 1-79) comprising the NLS, and the C-terminal region of
Rex (amino acids 79-95) comprising the NES region of Rex, restored Rev-
mediated RNA transport in A9 cells, suggesting that a putative murine cell inhibitor
of Rev-function might recognize NES domain of Rev.
NF90 is encoded by the ilf-3 gene, which by alternative splicing [11,12] gives rise
to a family of double stranded RNA binding domain(DRBD) proteins that include
NF90, NF110, MPP4 90, MPP4 110, ILF-3, NFAR-1 and NFAR-2, which are
implicated in different functions such as transcription, RNA splicing, RNA editing
and export. It is unclear if any of the DRBD proteins directly influence Rev-
dependent RNA transport.
The proteins in this family are characterized by the presence of two C-terminal
dsRNA binding domains (DRBD 1 and DRBD 2; Fig. 1) that allow the protein to
bind structured and duplexed RNAs [13-15]. NF90 has been found associated with
different viral RNAs, such as human Adeno-associated virus RNAII, the
encapsidation signal ε in Hepatitis B virus RNA, and bovine viral diarrhea virus
RNA [15-17]. Its central NLS domain and its N-terminal sequence homologous to
zinc finger regions interact with DNA and RNA [18], and a Leu-rich region functions
as an NES [16]. The NES region is similar to the NES consensus sequence
described in HIV-1 Rev.
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We studied a unique form of NF90, designated NF90ctv [19]. The C-terminal
variant, NF90ctv is distinct from other proteins encoded by ilf-3 in that its C-
terminal 67 amino acids (Fig. 1) is Arg-Gly-poor (RG-), whereas the corresponding
C-terminal region is Arg-Gly-rich (RG+) in all the other proteins of this family. NF90
is predominantly nuclear protein. In interphase cells however, about half of the
NF90 is tethered in the nucleus by RNA bound to protein with ds-RNA-dinding
motif, while in mitosis NF90 is phosphorylated and translocated to the cytoplasm,
without loss of its affinity for ds-RNA [20]. It has been reported that NF90 in the
cytoplasm can stabilize the IL-2 mRNA by binding to its AU-rich elements [21].
Moreover, its presence in complexes with the 3’ untranslated region (UTR) of Tau
mRNA [22] indicates that NF90 is part of the protein complex that interacts with the
Tau mRNA, and is essential for its exonal translocation. Thus the NF90 family of
proteins, due largely to their dsRNA recognition function, may affect gene
expression by targeted localization of structured RNA molecules.
Among the proteins encoded by the ilf-3 gene, NF90/NFAR’s proteins has been
reported to serve as substrate for PKR [23]. NF90 protein has characteristics
analogous to those of interferon (IFN) type 1 [19] such as the capacity to activate
genes involved in defense against viral infection. NF90 was originally reported to
be a transcription factor, although it does not possess DNA binding domains [13].
NF90 can negatively or positively regulate expression of a reporter gene,
depending on the viral promoter used [24]. The report that NF90ctv arrests HIV-1
replication in human osteosarcoma-derived cells [19], support the argument that
ectopic expression of NF90ctv results in overall stimulation of IFN response genes.
We reason that the attenuation of HIV-1 replication in NF90ctv expressing cells
may in part be due to the affinity of NF90ctv protein to the structured RNA
molecules essential in viral life cycle. That is, in addition to generalized induction of
the innate antiviral response pathway in NF90ctv-expressing cells [19], the binding
properties of NF90ctv to structured RNAs are likely to interfere with specific steps
of viral life cycle, particularly those that rely on precise protein:RNA interactions.
Thus, the overall antiviral response of NF90ctv may result from the stimulated
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innate immunity of the host following virus infection as well as from the ability of
NF90ctv to interfere with specific steps in the viral life cycle. Here we examined the
protein:protein and protein-dsRNA interaction properties of NF90ctv that inhibits
HIV-1 replication by blocking Rev function. The results suggest that NF90ctv
negatively affects the export of HIV-1 transcripts regulated by Rev. The NF90ctv-
mediated inhibition of Rev involved three specific regions of NF90ctv protein.
Results
NF90ctv inhibits Rev-dependent CAT activity
The CAT-RRE reporter gene (pCMV128; Fig. 1A) was used to evaluate the export
of transcripts that depend on Rev function. In this reporter system the cytoplasmic
expression of the CAT coding sequence depends on the presence of functional
Rev which allows efficient export of unspliced and incompletely spliced mRNAs.
Rev function was determined by the level of acetylated chloramphenicol
expression in HeLa cell extracts. As shown in Figure 2, CAT activity was absent
when the cells were transfected with the reporter gene alone (lane 1), or with the
pCI-neo empty expression vector (not shown). In the presence of Rev (pRSV/Rev),
there resulted a high level of CAT activity (lane 2). However, in cells expressing
NF90ctv along with Rev, the CAT activity was greatly reduced (compare lanes 2
and 3) indicating that NF90ctv interfered with the RNA export activity of Rev.
Next we characterized specific region(s) of NF90ctv (Fig. 1B) implicated in
inhibition of Rev function. The 5’- or the 3’- regions of the NF90ctv coding
sequence were cloned separately into the pCI-neo vector and the resulting
constructs were used to transfect HeLa cells in the presence of the reporter
pCMV128 and the Rev expression vector, pRSV/Rev. Both the N-terminal and the
C-terminal regions of NF90ctv inhibited Rev function (Fig. 2, lanes 4 and 5,
respectively), suggesting that at least two regions of NF90ctv contain sequences
that affect the Rev function.
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As outlined (Fig. 1B), two dsRNA binding motifs (DRBD 1 and DRBD 2) are located
in the C-terminal half of NF90ctv, where as the N-terminal region of NF90ctv may
be involved in protein-protein interactions. By comparison with other proteins in the
NF90 family, the N-terminal half of NF90ctv contains an NES region (Figure 1B),
and its C-terminal 67 amino acid sequence is deficient in arginine/glycine residues
(RG-). To evaluate the influence of specific NF90ctv domains on Rev-dependent
CAT activity, the NES, DRBD 1, DRBD 2 and RG- coding regions were cloned into
the pCI-neo vector (Fig. 1C), and used in cotransfection experiments in the
presence of CAT-RRE reporter, pCMV128 and the Rev expression vector,
pRSV/Rev. We first verified that the NES, DRBD 2 and RG- fragments without
NLS, translocate to the nucleus. Indeed, when these NF90 protein domains were
cloned into the fluorescent tagged vector, pmRFP and expressed as fusion
proteins, they were observed in the cytoplasm as well as in the nucleus (data not
shown).
As shown in Figure 2, the NES, DRBD 2 and RG- regions inhibited the Rev
dependent CAT activity (lanes 6-8 and 10 respectively); DRBD 1 effect was less
pronounced (lane 10); however, RG- showed a higher inhibitory effect on Rev
export activity. These results suggest that three regions of NF90ctv, the NES,
DRBD 2 and RG-, are involved in blocking Rev function, and collectively they
would strongly interfere with Rev function, possibly involving protein:protein or
protein:RNA interactions. Results similar to those presented in Figure 2 were
obtained with three independent transfection assays with each of the NF90ctv
domains. In control experiments, using the empty pCI-neo vector, there was no
induction of the CAT reporter gene with or without Rev (data not shown).
NF90 interact with REV protein
The N-terminus of NF90ctv protein includes a region that is likely to be involved in
protein:protein interactions [23]. In addition, its C-terminal RG- domain includes
three SH3 motifs (PXXP) that are known to be important in certain protein:protein
interactions [25,26]. Hence a possible mechanism of NF90ctv-mediated inhibition
 8
of Rev function may include sequestration of Rev involving NF90ctv:Rev protein
interaction. We tested the possibility by co-expressing Rev and NF90ctv in HeLa
cells transfected with pRSV/Rev or pOZ-Flag/NF90. We assessed the expression
of two proteins by Western blotting, using α-Rev31-50 and anti-FLAG antibodies.
Results showed that both Rev and NF90ctv proteins are expressed in HeLa cells
(data not shown).
To examine NF90ctv:Rev interaction we immunoprecipitated HeLa cell lysates with
α-Flag antibodies, 24 hr after cotransfection with pRSV/Rev and pOZ-Flag/NF90.
The resulting protein complex was enriched by addition of Protein A–agarose
beads, resolved by SDS-PAGE and analyzed by Western blot using the α-Rev31-50
antibodies. The results show that Rev co-immunoprecipitated with α-Flag
antibodies (Fig. 3, lane 1) in cells that expressed both the Rev and Flag/NF90
proteins, yielding a band of 28 kDa. In contrast, Rev was not detected in extracts of
HeLa cells that were not transfected with the Rev-expressing plasmid, pRSV/Rev
(lane 2), or in control assays where cell extracts were used prior to
immunoprecipitation (input cell extracts; lane 3). The results suggest that Rev
specifically associates with NF90ctv in vivo. As control a 28 kDa band was
observed with the purified Rev protein (Fig. 4B, lane 5). Taken together, the results
suggest that interaction between NF90ctv and Rev proteins could inhibit Rev
function either by sequestration of Rev in NF90ctv:Rev protein complexes that
would lead to a decrease in available Rev protein for Rev-mediated RRE
interaction. Alternatively, NF90ctv interaction with another cellular protein(s) may
be involved in blocking Rev export activity.
The RG- region of NF90ctv is involved in interaction with Rev
The C-terminal 67 amino acids (604-671) of NF90ctv designated RG-, possess
three SH3 motifs, that appear to be involved in protein:protein interactions [27].
This region of NF90ctv was cloned into pGEX-4T-3 leading to pGST/RG- that is
expected to yield a recombinant GST/RG- protein of ~33 kDa. The protein
expressed in E. coli was purified by affinity chromatography and analyzed by
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Western blotting using either a polyclonal α-GST/RG- or α-GST antibodies. With
both types of antibodies, a protein band migrating at the level of the recombinant
GST/RG- protein was detected. No ~33 kDa band appeared in similar Western
blots with preimmune sera (data not shown).
The purified GST/RG- protein was used to study the interaction of the RG- domain
of NF90ctv with Rev. It was coupled to a glutathione-Sepharose 4B column, and
used in pull-down assays by adding extracts from HeLa cells that express Rev, or
with purified Rev protein. After washing to remove unbound proteins, possible
Rev:RG- complexes were eluted, resolved by SDS-PAGE and visualized by
Coomassie blue staining. As shown in Figure 4 lane 4, when extract from HeLa
cells expressing Rev was added to the glutathione-Sepharose column, an
additional band of ∼25 kDa corresponding to Rev protein was detected. This band
was absent from control samples, i. e. lysates from IPTG-induced E. coli cells (lane
1), or from uninduced (lane 2) E. coli cells or with extracts from untransfected HeLa
cells (lane 3). Similar results were obtained when purified Rev expressed in E. coli
replaced the HeLa cell extracts previously transfected with pRSV/Rev (lane 5). It
should be noted that in all cases a double band of about 33 kDa was observed for
GST/RG- but only the faster-migrating band was recognized by the α-GST/RG- or
α-GST (Amersham) antibodies. The results indicate that the RG- region of NF90ctv
is involved in direct interaction with Rev, in agreement with the results obtained by
immunoprecipitation of full length NF90ctv (Fig. 3, lane 1).
NF90ctv and Rev show similar subcellular localization
To investigate whether expression of NF90ctv affects the cellular localization of
Rev, we investigated the localization of NF90ctv-GFP or of Rev-mRFP in Hela cells
24 h after transfection with either pNF90ctv/GFP or pGFP/Rev vectors alone, or
after co-transfection with pGFP/NF90 + pRev/mRFP (Fig. 5c). In agreement with
previous observations [10], Rev protein alone localized in the nucleus, mostly in
the nucleolus as confirmed by DAPI staining, and to a lesser extent in the
cytoplasm (Fig. 5b). Similar results were observed when HeLa cells were
 10
transfected with pRev/mRFP (data not shown). NF90ctv alone localized mostly in
the nucleus and in the nucleolus (Fig. 5a).Cells co-transfected with Rev and
NF90ctv showed co-localization of the two proteins in the same cellular
compartments (Fig. 5c’’’), i.e. in the nucleolus and the cytoplasm; in this case
NF90ctv localized mostly in the nucleolus and cytoplasm, and to lesser extent in
the nucleus. The results suggest that the subcellular distribution of NF90ctv is
altered in the presence of Rev: both proteins localized in the nucleus and in the
cytoplasm.
Interestingly, in the case of HeLa cells co-transfected with pGFP/NF90 +
pRev/mRFP in the presence of LMB, Rev was concentrated entirely in the
nucleolus, whereas NF90 was present both in the nucleus and in the nucleolus
(Fig. 5d’-d’’’), mostly in the nucleolus.
NF90ctv influences the expression of gene linked to RRE structure
To determine whether NF90ctv is directly implicated in export (and translation) of
transcripts linked to RRE, we used a construct containing the Gag and GFP coding
sequences linked to RRE. In this reporter system as well, the cytoplasmic
translocation and translation of Gag-GFP protein is Rev-dependent. Furthermore,
our results showed that Rev/GFP retained nuclear/nucleolar localization (Fig. 5, b),
as did NF90ctv which localized in the nuclear/nucleolar compartment (Fig 5, a). As
shown (Fig. 6), Gag-GFP mRNA that is linked to RRE, is expressed, transported to
the cytoplasm and translated either in presence of Rev or the NF90ctv (Fig. 6, a’
and b’, respectively). Rev protein in the presence of RRE, is transported to the
cytoplasm (Fig 6, a), where it is tracked with GFP (FIG. 6, a’’). In presence of
NF90ctv (Fig.6, b), Gag-GFP is distributed throughout the cell (Fig 6, b’), however,
NF90ctv is mostly localized in the nucleus/nucleolus (Fig. 6, b’’), suggesting that
RRE influences localization of NF90ctv. Overall, the results show that either Rev
protein (Rev/mRFP) or NF90ctv (NF90/mRFP) influence Gag-RRE-GFP
expression, suggesting that NF90ctv may influence the nucleocytoplasmic
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translocation of RRE containing transcripts, analogous to Rev function. The results
shown in figure 6 were observed in 4 independent experiments.
Discussion
The space of interactions between viral and host elements is complex, and our
understanding of these dynamics is incomplete. In this study we explored whether
the NF90ctv-mediated inhibition of HIV-1 Rev involved Rev-NF90ctv interaction.
The results presented here show that NF90ctv inhibits the Rev mediated export of
viral RNA. To refine this observation, and study its molecular mechanisms, we
created a series of vectors containing segments of the NF90ctv gene to use in
transfection studies. We investigated the possibility that specific regions of
NF90ctv may be involved in blocking Rev-mediated RNA export activity, by
expressing the NF90ctv regions in HeLa cells. Three regions of NF90ctv in
particular diminished Rev function, the NES, DRBD 2 and the C-terminal RG-.
The region of NF90ctv with the greatest inhibition of Rev function, the RG- domain,
consists of the C-terminal 67 amino acids. This domain contains three SH3 motifs
that are rich in Pro, which has been described to be involved in protein:protein
interactions [31]. SH3 motifs are highly conserved and are present in many
proteins that interact with RNAs. We suggest that the SH3 motifs of NF90ctv may
be involved in the Rev:NF90ctv interaction to block Rev function.
In addition, studies have indicated that NF90 possesses several regions capable of
protein:protein interactions; including PKR [32,33], NF45 [16], and eIF-2 [26].
Protein motifs capable of interacting with dsRNAs can also participate in
protein:protein interactions, such as homodimerization, as in the case of Rev. The
active homodimers of Rev protein form complexes with the RRE structure [34,35].
Proteins with dsRNA binding motifs can also interact with dsRNA ligands bound to
proteins implicated in innate immunity and defence against viral infections, such as
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PKR [36,37]. The detailed elucidation these interactions will be required to
understand the dynamics of viral – host interactions.
The NES region of NF90ctv used in this study comprises amino acids 81-190 that
include a Leu-rich sequence, present in the different NF90 isoforms encoded by
the ifl-3 gene [24]. This region contains the LX3LX3LXL sequence, similar to the
consensus LX2-3LX2-3LXL reported to be part of the NES in Rev [38]. The NES
domain of NF90ctv has been suggested to play an important role in the shuttling of
the protein between the nucleus and the cytoplasm that is required for IL-2 mRNA
translocation and stabilization [24]. Both Rev export [7] and NF90ctv export are
LMB-sensitive. Since the NES motif located in the N-terminal region of NF90ctv is
similar to the hydrophobic Leu-rich region present in proteins [24] known to recruit
the exportin Crm1 [3], we suggest that export of NF90ctv to the cytoplasm may be
Crm1-dependent (Fig. 7b). This is supported by the observation that in cells treated
with leptomycin B (Fig. 5d) NF90ctv is restricted in the nucleus (mostly in the
nucleolus), suggesting that Crm1 recognizes the NES domain of NF90ctv.
Following cell activation with 12-O-tetradecanoyl phorbol-beta-acetate and calcium
ionophore A23187, a major portion of GFP/NF90 was translocated to the
cytoplasm, and this translocation was inhibited by pretreatment with LMB [24].
When NF90ctv is overexpressed in presence of the Gag gene linked to RRE, the
Gag-RRE transcript is translocated to the cytoplasm (Fig. 6). We propose that
competition between NF90ctv and Rev for Crm1 binding is a possible mechanism
of interference with Rev function and that the interaction between NF90ctv and Rev
influences the affinity of viral protein for RRE RNA structure (Fig. 7d).
However, since NF90ctv contains two dsRNA binding motifs, a direct interaction
between NF90ctv and the HIV-1 RRE RNA structure may be equally important in
blocking Rev function. These two DRBDs bind to the small and highly structured
human Adenovirus transcript designated Adeno-associated virus RNA [18], to the
highly conserved encapsidation signal ε of the Hepatitis B pregenomic RNA [19],
and also to the 3’ UTR of Tau mRNA [25]. We investigated whether NF90ctv could
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bind the RRE structure. Our results suggest that NF90ctv is able to bind to RRE,
leading to the expression of the protein coding sequence linked to the RRE-RNA
structure. Our results suggest that interaction between NF90ctv and Rev protein
(Fig7c), as well as direct interaction between NF90ctv and RRE RNA structure may
affect RNA export from the nucleus (Fig. 7b). We suggest that competition between
NF90ctv and Rev for RRE binding could in part explain the decrease of Gag
expression. However, the overall molecular mechanisms of NF90ctv mediated
antiviral response will require further studies.
Rev protein has been reported to reside mainly in the nucleus [2,27], and is
translocated to cytoplasm in presence of RRE (Fig. 6a and Fig. 7a). Rev shuttles
between the nucleus and cytoplasm, since it harbours the NLS domain that
interacts with Importin β. The NES domain of Rev is recognized by Crm1/exportin 1
[39]. Substitution of Rev and RRE by an export promoting sequence construct,
RTE m26 – CTE, produces infectious virus [40], suggesting that export is indeed a
primary function of Rev:RRE. Similar to Rev, NF90 has been described mainly in
the nucleus [24]; yet, it can shuttle between the nucleus and the cytoplasm due to
its NES and NLS motifs [24]. When NF90ctv is expressed in presence of RRE
RNA structure (GFP-RRE), it is tethered in the nucleus, whereas mRNA linked to
RRE would normally be exported to the cytoplasm.
Overall, the results are consistent with a mechanism of inhibition of Rev based on
the interaction of Rev protein with specific domains of NF90ctv. The Rev-NF90ctv
interaction may prevent Rev homodimer formation, an essential step in interaction
of Rev with RRE. For the export of unspliced or incompletely spliced transcripts to
be efficient, Rev must be imported back into the nucleus where it must reach a
specific concentration [2] to induce complex formation with the RRE. The
transdominant Rev mutant, RevM10, that inhibits Rev activity [41], is restricted to
the nucleus and competes with Rev for interaction with the RRE. Rev-dependent
export has been reported to be specifically inhibited by LMB [42] which prevents
the interaction between Rev and Crm1. Likewise Sam68∆C, (i.e. the cell protein
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Sam68 devoid of its C-terminal domain), inhibits Rev activity, thereby preventing
the transcripts from entering the translation machinery [43]. The authors conclude
that Sam68∆C leads to perinuclear accumulation of the unspliced or incompletely
spliced mRNAs of HIV-1.
Conclusion
The results described here suggest a novel means of inhibition of HIV-1 Rev
function based on direct interaction between NF90ctv and Rev, interfering with the
export activity of Rev (Fig. 7). To our knowledge, no cellular protein has to date
been reported to have such an effect. The antiretroviral compounds presently in
use may be of limited use due to emerging drug resistant viral strains. Results
described here open the possibility of exploring novel therapeutic approaches
against HIV-1/AIDS, based on NF90-mediated inhibition of Rev.
Methods
Constructs and plasmids
The pEFX90 vector harboring the entire human NF90 coding sequence was kindly
provided by P. N. Kao (Stanford Univ., Calif.). To produce Flag/NF90, the NF90
coding sequence was recovered from pEFX90 by NcoI digestion and subcloned
into the pUC18 vector upstream of and in-frame with the Flag-coding sequence.
The Flag/NF90 coding sequence was then excised by NsiI and MscI digestion and
ligated into the pOZ vector kindly provided by Dr. B. Howard (NIH) and previously
cleaved by XhoI and NsiI, yielding the pOZ-Flag/NF90.
The pCI-neo/NF90 construct that allows expression of NF90ctv was described
previously [19]. The NF90N-terminal and NF90C-terminal coding sequences were
recovered from pCI-neo/NF90 by NheI/XbaI and XbaI/NotI digestion respectively
and cloned into pCI-neo vector cleaved with the same enzymes, producing pCI-
neo/N-ter NF90ctv and pCI-neo/C-ter NF90ctv respectively. To express other
regions of NF90ctv proteins (NES, DRBD 1, DRBD 2, RG-; Fig. 1C) the
appropriate regions of cDNA were amplified from pCI-neo/NF90 by PCR using
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specific primers (Table 1) and after EcoRI/SmaI digestion the products were
inserted into pCI-neo using the same restriction enzymes.
The pcsRev/GFP was kindly provided by Dr. George Pavlakis (National Cancer
Institute, Frederick, Md). The reporter plasmid pCMV128 (provided by Dr. Thomas
J. Hope, Northwestern University, Chicago) carries the second intron of HIV-1 with
the RRE structure downstream of the CAT coding sequence (Fig. 1A) and
therefore the expression of CAT strictly depends on Rev:RRE interaction for export
of the CAT coding sequence [10]. pRSV/Rev that expresses Rev was kindly
provided by Dr. T. J. Hope; the pSGT-5(SDM/RRE/CM-GFP) was kindly provided
by Dr. S. Arya (NCI/NIH) and contains the HIV-1 Gag gene and the GFP gene
linked to HIV RRE structure. The GFP-coding pEGFP-N1 was from Clontech.
To obtain the pRev/mRFP construct that expresses the monomeric red fluorescent
protein (mRFP), the following strategy was used. The mRFP cassette was
amplified from pcDNA3 (kindly provided by R. Y. Tsien, University of California,
San Diego) using the 5´primer GGATCCGCGGCAGACCATGGCTAGCA and the
3´primer GCGGCCGCTTAGGCGCCGGTGGAGTG. The 5´primer presents a
BamHI site (underlined) and a Kozak sequence, and the 3´primer a NotI site
(underlined). On the other hand, pEGF-N1, which expresses the GFP, was cleaved
with BamHI and NotI to delete the EGFP cassette, and replaced it by the mRFP
PCR product to obtain the pmRFP construct used to transform Escherichia coli
DH5α. Rev was amplified from pRSV/Rev using the 5´primer
GAATTCTGCCGCCACCATGGCAGGAAGAAGCGGA (EcoRI underlined) and the
3´primer CCCGGGTTCTTTAGCTCCTGACTCCAA (SmaI underlined). The PCR
product was digested with EcoRI/SmaI and ligated into pmRFP previously digested
with the same enzymes to obtain the pRev/mRFP construct.
To introduce the RG- region of NF90ctv (Fig. 1C) into pGEX-4T-3 (Amershan), the
corresponding region was released from pCI-neo/RG- NF90 using EcoRI/SmaI and
cloned into pGEX-4T-3, yielding pGST/RG- that codes for the GST/RG- protein.
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Cell culture and transfection
A human osteosarcoma cell line stably transduced with CD4 and CXCR4, a T-
tropic HIV-1 target cell line (GHOST/CD4+/CXCR4+), was maintained as described
[19] except that fetal bovine serum was from Invitrogen, or from Vecol, Colombia.
Cells were plated at ~3 X 105 cells per 35 mm-diameter dish 24 h before
transfection with 2 µg each of the appropriate plasmid DNA using Superfect
(Qiagen) following the manufacturer’s instructions. Cells were harvested 24 or 48 h
after transfection and lysed as described [10]. The protein concentration of lysates
was determined by the Bradford assay (Bio-Rad).
To evaluate expression of Rev and Flag/NF90 following co-transfection with
pRSV/Rev and pOZ-Flag/NF90, cell extracts were analyzed by SDS-PAGE, the
proteins transferred to a polyvinylidene-difluoride membrane (PVDF; Bio-Rad), and
immunodetected with α-Rev31-50 or α-Rev71-90 antibodies (generously supplied by
S. Marques, George Washington University), or α-Flag antibodies (Sigma).
CAT assay
HeLa cells were co-transfected with the plasmid constructs outlined in Table 1. To
normalize transfection efficiency, the pEGFP-N1 control plasmid was included in
each transfection assay. Cell lysates containing equal amounts of protein were
used in the CAT assays performed as previously described [10]. The results are
presented as fold increase or decrease in CAT activity measured as
chloramphenicol acetylation normalized proteins from cells transfected with the
pCMV128 reporter plasmid alone or the pCI-neo empty expression vector for NF90
as negative control.
Immunoprecipitation and immunoblot analysis
For the immunoprecipitation assays, 4 X 105 HeLa cells were grown to about 80%
confluence and cotransfected with 1.5 µg each of pRSV/Rev and pOZ-Flag/NF90,
and after 24 h extracts were prepared as described above. Cell extracts (35 µl)
were preincubated overnight at 4ºC with 5 µl of α-Flag antibodies with gentle
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shaking. Protein A agarose (10 µl; Invitrogen) was then added and incubation
continued for 3 h. The precipitate was recovered by centrifugation, washed 3 times
in PBS 1X and the resin suspended in 20 µl of 4X Laemmli buffer. The protein
suspension was analyzed by SDS-PAGE, transferred to a PVDF membrane and
probed using α-Rev31-50 antibodies. The same amount of HeLa cell extract prior to
immunoprecipitation was used as input control in western blot assays.
Expression and purification of the recombinant GST/RG- protein in E. coli
E. coli XL1 Blue cells transformed with pGST/RG- were induced or not overnight
with 0.5 mM IPTG and lysed using lysis buffer (50 mM Tris-Cl pH 8.0, 1 mM EDTA,
100 mM NaCl and 1 mg/ml of lysozyme). The recombinant protein was purified
using a glutathione-Sepharose 4B column (MicroSpinTM GST Purification Module,
Amersham) following the manufacturer’s instructions. The recombinant protein was
verified by SDS-PAGE and by immunoblotting with α-GST (Amersham) or α-
GST/RG- polyclonal antibodies.
Determination of NF90 RG-/Rev interaction by affinity chromatography
After binding the GST/RG- protein to the glutathione-Sepharose 4B column,
extracts from 106 HeLa cells transfected with pRSV/Rev, or 15 µg of purified Rev
protein [40] [obtained through the AIDS Research and Reference Reagent
Program, Division of AIDS, and NIAID, NIH: HIV-1 (wild type) from D. Rekosh, M.-
L. Hammarskjöld, and M. Orsini] were added to the column. After several washes
to remove unbound protein, the GST/RG-:Rev protein complex was eluted and
analyzed by SDS-PAGE and the proteins detected by Coomassie staining.
Cell localization
To determine if NF90ctv influences the cellular localization of Rev, HeLa cells (8 X
104) were co-transfected either with 1µ pRev/mRFP alone, with 1µ pRev/mRFP +
1µ pGFP/NF90 or with 1µ pGFP/NF90 alone; 1µ pmRFP was used as negative
control. After 24 h, the cells were fixed for 20 min with 2% paraformaldehyde at
room temperature. Following three washes with 1X PBS, the nuclei were stained
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with 4-6-diamidino-2-phenylindol (DAPI), the cells were mounted with Citifluor
(Canterbury, UK) and the GFP or mRFP was detected using a Leica SP2 AOBS
confocal microscope with a 63X, 1.32NA PlanApo lens using an Argon laser (488
nm) or a Krypton laser (568 nm), respectively. The images were assembled using
Adobe PhotoShop.
To study the effect of leptomycin B (LMB) on the subcellular localization of Rev and
NF90ctv, HeLa cells were co-transfected as described above, and 24 h later, 50
ng/ml of LMB were added and incubation continued for 2 h at 37°C in 5% CO2. The
cells were then fixed following the procedure described above and observed using
a Leica SP2 AOBS confocal microscope.
RRE-binding study
To examine if NF90 is able to bind the RRE RNA, the HeLa cells were transfected
with either 1µ pRev/mRFP alone or with 0.4µ pSGT-5(SDM/RRE/CM-GFP) or with
1µ pNF90/mRFP with or without 0.4µ pSGT-5(SDM/RRE/CM-GFP). As negative
control, we used the HeLa cells trasnfected only with pSGT-5(SDM/RRE/CM-
GFP). After 24 h, the GFP or mRFP was detected by confocal microscopy, as
described above.
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Table 1.
Primers used to amplify regions of NF90ctv by PCR for cloning into the pCI-neo
vector.
Amplified
region
Construct
5’-primer:
5'GGGGGGGAATTCGCTAGCCGCCACCAATGCAGAAGACGGAGCACATGAC3'
3’-primer:
5'GGGGGGCCCGGGGCGGCCGACTAGATGGTCAGGGACAATGGACGCTCTTT3'
NES pCI-neo/NES NF90
5’-primer:
5'GGGGGGGAATTCGCTAGCCGCCACCAATGAATGCCCTGATGCGGTTGAA3'
3’-primer:
5'GGGGGGCCCGGGGCGGCCGACTAAGCACCCGTCGGCAAGCCCATGTCCTG3'
DRBD 1 pCI-neo/DRBD 1 NF90
5’-primer:
5'GGGGGGGAATTCGCTAGCCGCCACCAATGAAGAACCCAGTCATGGAGCTG3'
3-primer:
5'GGGGGGCCCGGGGCGGCCGACTAAGGGAAAAGTTTTTCTAGGGCAGCAAG3'
DRBD 2 pCI-neo/DRBD 2 NF90
5’-primer:
5'GGGGGGGTCGACCGCCACCAATGAAGCTTTTCCCTGACACCCCTCTCGCC3'
3’-primer:
5'GGGGGGCCCGGGCGGCCGCCTATGTAGCCTCCATGGTTGGCGCCACCAAA3'
RG- pCI-neo/RG- NF90
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Legend of figures
Figure 1. Schematic representation of (A) pCMV128 (CAT-RRE reporter), and (B)
the NF90ctv regions investigated here. (C) The NF90ctv domains were cloned into
pCI-neo and used in this study. The vertical arrows correspond to the SH3 motifs
present in RG- region.
Figure 2. Effect of NF90ctv protein domains on the level of expression of CAT.
HeLa cells were cotransfected with CAT-RRE, and with different constructs that
code for Rev protein and the NF90ctv domains. After cell lysis, 14C-labelled
chloramphenicol and acetyl CoA were added to the extracts and the CAT activity
determined. The construct included in each assay is indicated above the lanes.
Vertical arrows highlight the constructs leading to the strongest decrease in
acetylation of chloramphenicol. Similar results were obtained in three independent
experiments. When the cells were transfected only with the empty expression
vector for NF90 (pCI-neo), acetylation of chloramphenicol was not observed (not
shown).
Figure 3. Immunoprecipitation. HeLa cells were cotransfected with pRSV/Rev and
pOZ-Flag/NF90; 24 h post-transfection, the cells were lysed, α-Flag antibodies
were added and the proteins precipitated by adding protein A agarose. The
samples were analyzed by SDS-PAGE, and the proteins transferred to a PVDF
membrane were immunodetected using α-Rev31-50 antibodies. Lane 1, extracts
from HeLa cells cotransfected with both constructs. Lane 2, extracts from
untransfected HeLa cells. Lane 3, same amount of HeLa cell extract prior to
immunoprecipitation (input control). Arrow indicates the protein band (∼28 kDa)
corresponding to Rev.
Figure 4. Interaction between the NF90ctv RG- domain and Rev by affinity
chromatography. (A) The GST/RG- recombinant protein was expressed in E. coli,
the cell extracts coupled to a glutathione-Sepharose 4B column was used in pull-
down assays with HeLa cell extracts previously transfected with pRSV/Rev (lane 4)
or the control lysate (lane 3). A protein band corresponding to Rev (arrowhead,
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lane 4) was detected when extracts from HeLa cells that expressed Rev were
added to the GST/RG- protein bound column; such a band was absent from control
HeLa cell extract (lane 3). Lane 1, GST/RG- purified from E. coli induced by IPTG,
and lane 2, purified from non induced E. coli cells. (B) Similar assays performed
with purified Rev protein from E. coli in place of HeLa cells extracts. Arrow in lane 5
indicates the position of Rev. This band was not observed in absence of Rev (lane
6).
Figure 5. Subcellular localization of the Rev and NF90ctv proteins observed by
fluorescence microscopy in confocal optical sections. HeLa cells were transfected
with pGFP/NF90 or pGFP/Rev and GFP was visualized with an Argon laser at 488
nm. NF90 localized in the nucleus and nucleolus; Rev localized in the nucleus,
nucleolus and cytoplasm (panels a and b). To study the effect of NF90ctv on Rev
localization, HeLa cells were cotransfected with both expression vectors and the
proteins were observed in confocal optical sections; the mRFP was visualized
using a Krypton laser at 568 nm. Both protein colocalized in the similar subcellular
compartments (c’-c’’; d’-d’’ are the same as c’-c’’’). In the presence of 50 ng/ml of
LMB and both proteins localized mostly in the nucleolus. Bar=5 µm.
Figure 6. NF90ctv affects structured-RNA translocation. HeLa cells were
cotransfected with pRev/mRFP and pSGT-5(SDM/RRE/CM-GFP) or with
pNF90/mRFP and pSGT-5(SDM/RRE/CM-GFP). The constructs represent HIV-1
Gag and GFP genes linked to RRE, making their expression dependent on Rev.
The reporter gene (GFP) linked to RRE is expressed either in presence of Rev or
NF90ctv (a and b, respectively). As controls HeLa cells were transfected with each
construct alone. In presence the RRE, Rev localized mainly in the cytoplasm (a),
colocalized with the GFP reporter (a’’). However, NF90ctv in the presence of RRE,
preferentially localized in the nucleus/nucleoli (b), and GFP reporter was distributed
in the cytoplasm and in the nucleus.
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Figure 7. Model for regulation of Rev protein by NF90. The HeLa cells are
cotransfected with the respective plasmids. In (a), the transcript of the gene linked
to RRE is recognized by Rev and forms a complex with CRM1, it is exported to the
cytoplasm, where it is translated by the ribosome. In (b) based on the data
presented herein, we suggest that NF90 is able to recognize the transcript of the
gene linked to RRE, and then it is exported to the cytoplasm and translated. In (c)
we suggest that this process is CRM1-dependent. Because our
immunoprecipitation results show that NF90 interacts with Rev and their
colocalization in the cytoplasm is CRM1-dependent, In (d) we propose that the
affinity of Rev or NF90 for RRE, is affected by protein-protein interaction (NF90-
Rev), with as a consequence low expression of the gene linked to RRE; another
possibility would be that the interaction of NF90 with Rev, alters the conformation
of Rev, allowing decreased access to RRE.
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